CRKN
Crown Electrokinetics Corp.
NASDAQ · Basic Materials · Chemicals - Specialty · US
$0.00
−80.00%Income statement
| Metric | TTM | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 21.8M | 19.7M | 153.0K | — | — |
| Cost of Revenue | 22.6M | 20.4M | 886.0K | — | — |
| Gross Profit | (777.0K) | (714.0K) | (733.0K) | — | — |
| Operating Expenses | |||||
| R&D Expense | 3.8M | 3.4M | 2.2M | 4.1M | 3.4M |
| SG&A Expense | 25.9M | 20.0M | 15.0M | 11.0M | 18.7M |
| General & Admin Expense | 23.2M | — | — | — | — |
| Selling & Marketing Expense | — | — | — | — | — |
| Other Expenses | (212.0K) | — | 1.4M | — | — |
| Total Operating Expenses | 29.5M | 23.4M | 18.6M | 15.1M | 22.1M |
| Cost and Expenses | 52.1M | 43.8M | 19.5M | 15.1M | 22.1M |
| Operating Income (EBIT) | (30.3M) | (24.1M) | (19.3M) | (15.1M) | (22.1M) |
| Non-Operating | |||||
| Interest Income | — | — | — | — | — |
| Interest Expense | (1.9M) | 994.0K | 9.4M | 7.0K | 538.0K |
| Net Interest Income | 860.0K | (994.0K) | (9.4M) | (7.0K) | (538.0K) |
| Other Non-Op Income/Expense | (696.0K) | (8.3M) | (9.7M) | 793.0K | (15.0M) |
| Non-Operating Income (excl Interest) | 779.0K | 826.0K | 387.0K | — | — |
| EBT (Pre-Tax Income) | (37.5M) | (32.5M) | (29.0M) | (14.3M) | (37.2M) |
| Income Tax Expense | — | — | — | — | — |
| Bottom Line | |||||
| Net Income | (31.0M) | (25.9M) | (29.0M) | (14.4M) | (37.2M) |
| Earnings from Cont. Ops | (31.0M) | (25.9M) | (29.0M) | — | (37.2M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (37.0M) | (32.5M) | (29.7M) | (14.4M) | (37.2M) |
| Per Share | |||||
| Basic EPS | $17.73 | ($0.55) | ($222.31) | ($7,417.34) | ($26,335.22) |
| Diluted EPS | $17.73 | ($0.55) | ($222.31) | ($7,417.34) | ($26,335.22) |
| Revenue Per Share | $1.30 | $0.33 | $1.15 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 16.7M | 59.2M | 133415 | 1937 | 1411 |
| Diluted Shares Outstanding | 16.7M | 59.2M | 133415 | 1937 | 1411 |
| Profitability Metrics | |||||
| EBITDA | (28.9M) | (23.1M) | (18.3M) | (14.6M) | (21.8M) |
| D&A | 2.2M | 1.9M | 1.4M | 774.0K | 301.0K |
| EBIT | (31.1M) | (25.0M) | (19.7M) | — | (22.1M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Mar 1, 2025